OrisDX

Chicago, United States

OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.

$4.0M raised

Jun 2025

Seed

Top Investors

Polsky Center for Entrepreneurship and Innovation Revere Partners Illinois Department of Commerce & Economic Opportunity The University of Chicago Medicine SMILE Health

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about OrisDX

How much funding has OrisDX raised?

OrisDX has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.

Who are OrisDX's investors?

OrisDX's investors include Polsky Center for Entrepreneurship and Innovation, Revere Partners, Illinois Department of Commerce & Economic Opportunity, The University of Chicago Medicine, SMILE Health.

Where is OrisDX headquartered?

OrisDX is headquartered in Chicago, United States.

What does OrisDX do?

OrisDX provides a saliva-based molecular detection method to check oral cavity pre-malignancies and cancers.

What stage is OrisDX at?

OrisDX is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 10, 2025.

MLA

"OrisDX — Funding & Investors." VCBacked, June 10, 2025, https://www.vcbacked.co/company/orisdx. Accessed July 2, 2026.

APA

VCBacked. (2025). OrisDX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/orisdx

Wikipedia (cite web)

{{cite web |title=OrisDX — Funding & Investors |url=https://www.vcbacked.co/company/orisdx |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 10, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K